http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2009035216-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_381a3aec2a21949e7f0ca976a79f9c85 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b1278a912a8128fb9666cf70cfdb6afd http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3832e057afd7a50b9f681424c6d87234 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f24c1fca4d748a569e5033822d2ece8d |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2035-128 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-30 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-44 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 |
| classificationIPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-12 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-44 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K48-00 |
| filingDate | 2008-08-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8941f0e7d6e8ebfbacf6450886930a23 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b586187387dac4dd97fe57864493f06f http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bfc8fd98af9bef24c37ecb5a340f05e7 |
| publicationDate | 2009-03-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | WO-2009035216-A1 |
| titleOfInvention | Cell delivery system for cell therapy comprising cells derived from embryonic stem cells |
| abstract | The present invention provides a cell delivery system for cell therapy including cells derived from embryonic stem cells, which is formed by inserting the cells derived from embryonic stem cells into a carrier formed of matrigel. The cell delivery system is transplanted into the region of a living body, which does not directly in contact with a disease region; migration of the cells derived from embryonic stem cells from the transplanted region is inhibited by the carrier; and the cell delivery system is finally removed from the transplanted region. In the cell delivery system of the present invention, cell therapy is accomplished only by substances secreted from the cells derived from embryonic stem cells, such as cytokine, while the cells derived from embryonic stem cells are not directly in contact with a disease region. Therefore, the cell delivery system according to the present invention can avoid any formation of cancers and tumors, which may be caused from direct transplantation of cells derived from embryonic stem cells into a living body. |
| priorityDate | 2007-09-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 40.